Dr. Mark Allan Ahlman, MD

Dr. Ahlman practices at UVA University Medical Center in Charlottesville, Virginia.

Dr. Ahlman's NPI, 1609038272, was assigned on June 25, 2008. Dr. Ahlman graduated from Medical College of Georgia in 2008. Dr. Ahlman holds Georgia license 93832.

Dr. Ahlman's primary practice is UVA University Medical Center, at 1215 Lee St, Charlottesville, VA 22908 in Charlottesville City. The practice phone is (434) 924-2762.

Dr. Ahlman's primary practice is UVA University Medical Center in Charlottesville, Virginia. Dr. Ahlman is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Ahlman to 4 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ahlman practices, 5 sites in all. Vendor and product names are available with a free account.

Nuclear medicine is Dr. Ahlman's primary specialty in the NPI Registry, under taxonomy code 207U00000X. Dr. Ahlman is board certified in nuclear medicine by the American Board of Nuclear Medicine. Dmand AI has Dr. Ahlman's licenses on file in 4 states: Georgia, Maryland, Virginia and South Carolina.

CMS data shows 413 Medicare services from Dr. Ahlman across 7 procedure codes in 2024, for 430 Medicare patients. Medicare paid $27,182 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 430 Medicare patients who saw Dr. Ahlman in 2024. The largest group is 65 to 74, with 210 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ahlman's median patient age at 62, with 50% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Ahlman for performance year 2024, reported through an alternative payment model (APM). Dr. Ahlman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 79 papers to Dr. Ahlman, published from 2013 to 2025. 2019 was the busiest year, with 9. The most frequent topics are Fluorodeoxyglucose F18, Positron-Emission Tomography and Positron Emission Tomography Computed Tomography. Dr. Ahlman has published most often in Arthritis Rheumatol. Dr. Ahlman's most frequent co-authors are David Alan Bluemke, MD, Kaitlin Anne Quinn, MD and Nehal N. Mehta, MD.

CMS Open Payments shows 11 general payments to Dr. Ahlman from 4 drug and device companies from 2023 to 2025. Travel and lodging make up the largest share, 65% of the total. Telix Pharmaceuticals paid the most, $1,844.

Dr. Ahlman graduated from Medical College of Georgia in 2008.

Dr. Ahlman is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.